Tidemark LLC Makes New Investment in HCA Healthcare, Inc. (NYSE:HCA)

Tidemark LLC bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 119 shares of the company’s stock, valued at approximately $36,000.

Other large investors have also recently bought and sold shares of the company. GSA Capital Partners LLP bought a new stake in shares of HCA Healthcare in the 3rd quarter valued at $567,000. CIBC Asset Management Inc raised its holdings in shares of HCA Healthcare by 4.9% during the third quarter. CIBC Asset Management Inc now owns 29,427 shares of the company’s stock valued at $11,960,000 after purchasing an additional 1,362 shares during the period. Natixis Advisors LLC grew its stake in shares of HCA Healthcare by 2.3% in the 3rd quarter. Natixis Advisors LLC now owns 110,105 shares of the company’s stock valued at $44,750,000 after buying an additional 2,459 shares during the period. Atlanta Consulting Group Advisors LLC bought a new position in HCA Healthcare in the third quarter worth approximately $311,000. Finally, Planning Directions Inc. acquired a new stake in HCA Healthcare in the 3rd quarter valued at $236,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now owns 15,412 shares of the company’s stock, valued at $4,971,757.08. The trade was a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.60% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the company. KeyCorp decreased their price objective on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a report on Tuesday, January 7th. Truist Financial cut their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Wells Fargo & Company cut shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and cut their price target for the stock from $400.00 to $320.00 in a report on Monday, November 25th. Cantor Fitzgerald restated an “overweight” rating and issued a $405.00 target price on shares of HCA Healthcare in a research note on Monday, January 27th. Finally, JPMorgan Chase & Co. reiterated a “neutral” rating and set a $380.00 price target on shares of HCA Healthcare in a report on Tuesday, December 17th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $385.67.

HCA Healthcare Trading Up 1.6 %

NYSE:HCA opened at $319.82 on Monday. The company has a market cap of $78.74 billion, a P/E ratio of 14.56, a P/E/G ratio of 1.10 and a beta of 1.68. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The stock’s fifty day moving average price is $319.00 and its two-hundred day moving average price is $344.95.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the previous year, the firm earned $5.90 EPS. As a group, analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be issued a $0.72 dividend. The ex-dividend date is Monday, March 17th. This represents a $2.88 annualized dividend and a dividend yield of 0.90%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.